NORGESTREL

NORGESTREL was reported 1356 times

NORGESTREL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONTRACEPTION BREAKTHROUGH BLEEDING 1 0.1429
1 PREGNANCY ON ORAL CONTRACEPTIVE 206 0.0785
2 MENSTRUAL HEADACHE 1 0.0714
3 MENSTRUAL CLOTS 13 0.0542
4 POLYMENORRHOEA 155 0.0447
5 INTERMENSTRUAL BLEEDING 182 0.0325
6 ABNORMAL MENSTRUAL CLOTS 5 0.0286
7 HEAVY MENSTRUAL BLEEDING 245 0.0272
8 VULVOVAGINAL ULCERATION 1 0.0204
9 MENSTRUAL DISCOMFORT 2 0.0167
10 NONINFECTIVE OOPHORITIS 1 0.0149
11 NEUROLOGICAL INFECTION 1 0.0101
12 BIOCHEMICAL PREGNANCY 1 0.0093
13 PROGESTERONE INCREASED 1 0.0090
14 OVARIAN RUPTURE 1 0.0085
15 PREMENSTRUAL PAIN 1 0.0076
16 HEPATITIS C RNA POSITIVE 1 0.0058
17 MENOPAUSAL SYMPTOMS 13 0.0056
18 HYPOMENORRHOEA 15 0.0055
19 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
20 PREMENSTRUAL DYSPHORIC DISORDER 1 0.0049
21 LACTATION INSUFFICIENCY 1 0.0048
22 OVULATION PAIN 1 0.0048
23 DYSMENORRHOEA 52 0.0039
24 MENSTRUAL DISORDER 32 0.0039
25 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
26 OLIGOMENORRHOEA 8 0.0037
27 GENITAL BLISTER 1 0.0036
28 DAIRY INTOLERANCE 1 0.0036
29 CAROTID ARTERY THROMBOSIS 3 0.0035
30 MENSTRUATION DELAYED 32 0.0029
31 VULVOVAGINAL DRYNESS 8 0.0025
32 ACNE CYSTIC 7 0.0023
33 HORMONE LEVEL ABNORMAL 10 0.0020
34 MENSTRUATION IRREGULAR 51 0.0019
35 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
36 ADNEXA UTERI PAIN 2 0.0016
37 BREAST PAIN 16 0.0015
38 CYST RUPTURE 1 0.0015
39 NIPPLE PAIN 3 0.0015
40 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
41 PREMENSTRUAL SYNDROME 2 0.0015
42 BLOOD OESTROGEN DECREASED 1 0.0014
43 HAEMORRHAGE IN PREGNANCY 2 0.0014
44 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
45 BREAST TENDERNESS 10 0.0013
46 AMENORRHOEA 23 0.0013
47 ECTOPIC PREGNANCY 4 0.0013
48 RUPTURED ECTOPIC PREGNANCY 1 0.0013
49 INJECTION SITE BURNING 1 0.0013
50 MOOD SWINGS 39 0.0012
51 TESTICULAR ATROPHY 1 0.0011
52 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
53 LIGAMENT DISORDER 1 0.0011
54 VULVOVAGINAL PAIN 5 0.0010
55 BREAST DISCOMFORT 1 0.0010
56 VAGINAL HAEMORRHAGE 40 0.0009
57 VAGINAL DISCHARGE 9 0.0009
58 MOOD ALTERED 24 0.0009
59 CARBON DIOXIDE DECREASED 1 0.0009
60 LIBIDO DISORDER 1 0.0008
61 ADVERSE DRUG REACTION 68 0.0008
62 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
63 ACNE 53 0.0007
64 ABORTION 2 0.0007
65 NEGATIVE THOUGHTS 2 0.0007
66 SKIN STRIAE 1 0.0007
67 INFERTILITY 1 0.0007
68 EPICONDYLITIS 1 0.0007
69 MEAN CELL VOLUME DECREASED 1 0.0006
70 AFFECT LABILITY 6 0.0006
71 BREAST ENLARGEMENT 2 0.0006
72 CRYING 21 0.0006
73 ALOPECIA AREATA 1 0.0006
74 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
75 LOSS OF LIBIDO 5 0.0006
76 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
77 SEBORRHOEA 2 0.0005
78 PNEUMONIA KLEBSIELLA 1 0.0005
79 MENOMETRORRHAGIA 1 0.0005
80 ANGER 17 0.0005
81 HYPERPHAGIA 2 0.0005
82 LIPIDS INCREASED 1 0.0005
83 PSYCHOTIC SYMPTOM 1 0.0005
84 PHARYNGEAL ERYTHEMA 1 0.0005
85 INCREASED APPETITE 9 0.0005
86 EMOTIONAL DISORDER 14 0.0005
87 BRAIN FOG 7 0.0004
88 BLOOD LOSS ANAEMIA 1 0.0004
89 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
90 PUSTULE 1 0.0004
91 OVARIAN CYST 4 0.0004
92 VULVOVAGINAL PRURITUS 2 0.0004
93 FOOD CRAVING 2 0.0004
94 DEPRESSED MOOD 20 0.0004
95 ADVERSE REACTION 5 0.0004
96 BREAST SWELLING 1 0.0004
97 RHEUMATOID NODULE 1 0.0004
98 ABDOMINAL DISTENSION 36 0.0003
99 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
100 SKIN INJURY 1 0.0003
101 PRODUCT ADMINISTRATION ERROR 6 0.0003
102 WOUND COMPLICATION 1 0.0003
103 HAIR GROWTH ABNORMAL 2 0.0003
104 WEIGHT FLUCTUATION 3 0.0003
105 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
106 WEIGHT INCREASED 63 0.0003
107 ABORTION SPONTANEOUS 11 0.0003
108 EXTRA DOSE ADMINISTERED 11 0.0003
109 PRODUCT DOSE OMISSION ISSUE 79 0.0003
110 PANIC DISORDER 1 0.0003
111 CYST 3 0.0002
112 SELF-INJURIOUS IDEATION 1 0.0002
113 MIGRAINE 22 0.0002
114 VULVOVAGINAL DISCOMFORT 1 0.0002
115 IRON DEFICIENCY 1 0.0002
116 MUSCLE SPASMS 40 0.0002
117 DYSPAREUNIA 1 0.0002
118 YELLOW SKIN 1 0.0002
119 FLANK PAIN 2 0.0002
120 ABORTION INDUCED 2 0.0002
121 INTENTIONAL DOSE OMISSION 6 0.0002
122 ENDOMETRIOSIS 1 0.0002
123 STILLBIRTH 1 0.0002
124 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
125 INFLAMMATORY MARKER INCREASED 1 0.0002
126 DERMATITIS EXFOLIATIVE 1 0.0002
127 IRRITABILITY 12 0.0002
128 HOT FLUSH 15 0.0002
129 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
130 BIPOLAR DISORDER 2 0.0002
131 STRESS CARDIOMYOPATHY 1 0.0002
132 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
133 FOETAL GROWTH RESTRICTION 1 0.0002
134 SUICIDAL IDEATION 15 0.0002
135 VULVOVAGINAL BURNING SENSATION 1 0.0002
136 ADVERSE EVENT 15 0.0002
137 MENISCUS INJURY 1 0.0002
138 ABDOMINAL PAIN LOWER 4 0.0002
139 INCOHERENT 1 0.0002
140 TENDON DISORDER 1 0.0002
141 ALOPECIA 30 0.0002
142 APPETITE DISORDER 1 0.0002
143 SKIN REACTION 2 0.0001
144 MENTAL DISORDER 6 0.0001
145 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
146 PSYCHIATRIC SYMPTOM 1 0.0001
147 DEPRESSION 30 0.0001
148 HAEMOLYSIS 1 0.0001
149 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
150 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
151 PALLOR 3 0.0001
152 OVARIAN CANCER 1 0.0001
153 PERSONALITY CHANGE 1 0.0001
154 HEADACHE 66 0.0001
155 THROMBOTIC MICROANGIOPATHY 1 0.0001
156 NAUSEA 77 0.0001
157 TRANSFUSION 1 0.0001
158 PULMONARY THROMBOSIS 1 0.0001
159 ABDOMINAL PAIN 21 0.0001
160 ANXIETY 24 0.0001
161 BLOOD IRON DECREASED 1 0.0001
162 BACTERAEMIA 1 0.0001
163 PRESYNCOPE 2 0.0001
164 ABNORMAL WEIGHT GAIN 1 0.0001
165 HAIR COLOUR CHANGES 1 0.0001
166 DERMATITIS ALLERGIC 1 0.0001
167 HYPOPHAGIA 2 0.0001
168 RASH 34 0.0001
169 ABDOMINAL PAIN UPPER 16 0.0001
170 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
171 PLATELET COUNT INCREASED 1 0.0001
172 HAIR TEXTURE ABNORMAL 1 0.0001
173 SINUS CONGESTION 1 0.0001
174 MEDICATION ERROR 4 0.0001
175 HUNGER 1 0.0001
176 WITHDRAWAL SYNDROME 3 0.0001
177 IMPAIRED QUALITY OF LIFE 1 0.0001
178 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
179 GASTROENTERITIS 1 0.0001
180 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
181 FEELING ABNORMAL 16 0.0001
182 GYNAECOMASTIA 2 0.0001
183 PRODUCT USE COMPLAINT 1 0.0001
184 HALLUCINATION, AUDITORY 1 0.0001
185 PREMATURE DELIVERY 1 0.0001
186 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
187 SKIN DISORDER 2 0.0001
188 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
189 DYSURIA 2 0.0001
190 DIZZINESS 27 0.0001
191 HYPERSENSITIVITY 10 0.0001
192 THINKING ABNORMAL 1 0.0001
193 LETHARGY 3 0.0001
194 HAEMATOCRIT DECREASED 1 0.0001
195 TASTE DISORDER 1 0.0000
196 BODY TEMPERATURE INCREASED 1 0.0000
197 MOUTH ULCERATION 1 0.0000
198 RETCHING 1 0.0000
199 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
200 VOMITING 21 0.0000
201 PULMONARY OEDEMA 2 0.0000
202 THROAT IRRITATION 2 0.0000
203 URTICARIA 7 0.0000
204 MENTAL IMPAIRMENT 1 0.0000
205 FLUID RETENTION 2 0.0000
206 HYPERHIDROSIS 5 0.0000
207 UNRESPONSIVE TO STIMULI 1 0.0000
208 ECZEMA 2 0.0000
209 SEDATION 1 0.0000
210 JOINT STIFFNESS 1 0.0000
211 ANHEDONIA 1 0.0000
212 FATIGUE 29 0.0000
213 PAIN OF SKIN 1 0.0000
214 FREQUENT BOWEL MOVEMENTS 1 0.0000
215 ABNORMAL DREAMS 1 0.0000
216 FEELING COLD 1 0.0000
217 HAEMOPTYSIS 1 0.0000
218 DECREASED APPETITE 8 0.0000
219 PSYCHOTIC DISORDER 1 0.0000
220 PREMATURE BABY 1 0.0000
221 SUICIDE ATTEMPT 2 0.0000
222 LIMB DISCOMFORT 1 0.0000
223 EXPOSURE DURING PREGNANCY 2 0.0000
224 MALAISE 14 0.0000
225 HEAD INJURY 1 0.0000
226 DRUG INTERACTION 5 0.0000
227 HYPOTHYROIDISM 1 0.0000
228 LOSS OF CONSCIOUSNESS 4 0.0000
229 HEART RATE INCREASED 3 0.0000
230 FUNGAL INFECTION 1 0.0000
231 ABDOMINAL DISCOMFORT 5 0.0000
232 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
233 CONDITION AGGRAVATED 9 0.0000
234 DRUG INEFFECTIVE 39 0.0000
235 VISION BLURRED 4 0.0000
236 NIGHTMARE 1 0.0000
237 CONSTIPATION 6 0.0000
238 PANIC ATTACK 1 0.0000
239 ACCIDENTAL OVERDOSE 1 0.0000
240 PRODUCT USE ISSUE 5 0.0000
241 COLITIS 1 0.0000
242 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
243 PAIN 16 0.0000
244 BACK PAIN 6 0.0000
245 PALPITATIONS 3 0.0000
246 PARAESTHESIA 4 0.0000
247 THROMBOSIS 2 0.0000
248 POLLAKIURIA 1 0.0000
249 RECTAL HAEMORRHAGE 1 0.0000
250 DEVICE DISLOCATION 1 0.0000
251 SEPTIC SHOCK 1 0.0000
252 INTENTIONAL PRODUCT MISUSE 2 0.0000
253 LIVER DISORDER 1 0.0000
254 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
255 INCORRECT DOSE ADMINISTERED 5 0.0000
256 SKIN IRRITATION 1 0.0000
257 SKIN DISCOLOURATION 1 0.0000
258 WEIGHT DECREASED 6 0.0000
259 COGNITIVE DISORDER 1 0.0000
260 SWELLING 2 0.0000
261 RASH ERYTHEMATOUS 1 0.0000
262 CONTUSION 2 0.0000
263 AGGRESSION 1 0.0000
264 SOMNOLENCE 4 0.0000
265 FLUSHING 2 0.0000
266 HAEMOGLOBIN DECREASED 2 0.0000
267 DISTURBANCE IN ATTENTION 1 0.0000
268 RASH PRURITIC 1 0.0000
269 PRURITUS 7 0.0000
270 HAEMATOCHEZIA 1 0.0000
271 ANAPHYLACTIC REACTION 1 0.0000
272 BLISTER 1 0.0000
273 EYE PAIN 1 0.0000
274 FLATULENCE 1 0.0000
275 PRODUCT SUBSTITUTION ISSUE 1 0.0000
276 SEIZURE 2 0.0000
277 CHILLS 2 0.0000
278 NASAL CONGESTION 1 0.0000
279 VERTIGO 1 0.0000
280 DISCOMFORT 1 0.0000
281 FEELING HOT 1 0.0000
282 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
283 DIARRHOEA 10 0.0000
284 RHINORRHOEA 1 0.0000
285 DEEP VEIN THROMBOSIS 1 0.0000
286 SWELLING FACE 1 0.0000
287 PRODUCT DOSE OMISSION 1 0.0000
288 BLOOD CREATININE INCREASED 1 0.0000
289 INJECTION SITE PRURITUS 1 0.0000
290 INJECTION SITE REACTION 1 0.0000
291 SLEEP DISORDER 1 0.0000
292 SKIN BURNING SENSATION 1 0.0000
293 AGITATION 1 0.0000
294 HYPOAESTHESIA 2 0.0000
295 UNEVALUABLE EVENT 1 0.0000
296 BLOOD PRESSURE INCREASED 2 0.0000
297 INJECTION SITE SWELLING 1 0.0000
298 OFF LABEL USE 11 0.0000
299 DRY MOUTH 1 0.0000
300 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
301 TREMOR 2 0.0000
302 SKIN EXFOLIATION 1 0.0000
303 MYALGIA 2 0.0000
304 PYREXIA 4 0.0000
305 INSOMNIA 3 0.0000
306 TACHYCARDIA 1 0.0000
307 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
308 GASTROINTESTINAL DISORDER 1 0.0000
309 OROPHARYNGEAL PAIN 1 0.0000
310 BREAST CANCER 1 0.0000
311 DYSPNOEA 6 0.0000
312 DYSPHAGIA 1 0.0000
313 PULMONARY EMBOLISM 1 0.0000
314 ANAEMIA 2 0.0000
315 DYSPEPSIA 1 0.0000
316 SYNCOPE 1 0.0000
317 CHEST DISCOMFORT 1 0.0000
318 ERYTHEMA 2 0.0000
319 ILLNESS 1 0.0000
320 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
321 HAEMORRHAGE 1 0.0000
322 SEPSIS 1 0.0000
323 THROMBOCYTOPENIA 1 0.0000
324 EMOTIONAL DISTRESS 1 0.0000
325 OEDEMA PERIPHERAL 1 0.0000
326 INJECTION SITE ERYTHEMA 1 0.0000
327 DEHYDRATION 1 0.0000
328 DRY SKIN 1 0.0000
329 PRODUCT QUALITY ISSUE 1 0.0000
330 ARTHRALGIA 3 0.0000
331 INFECTION 1 0.0000
332 HOSPITALISATION 1 0.0000
333 CONFUSIONAL STATE 1 0.0000
334 CEREBROVASCULAR ACCIDENT 1 0.0000
335 URINARY TRACT INFECTION 1 0.0000
336 MYOCARDIAL INFARCTION 1 0.0000
337 NASOPHARYNGITIS 1 0.0000
338 CHEST PAIN 1 0.0000
339 ASTHENIA 2 0.0000
340 HYPERTENSION 1 0.0000
341 OVERDOSE 1 0.0000
342 PAIN IN EXTREMITY 1 0.0000
343 FALL 1 0.0000
344 DEATH 1 0.0000